![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » J&J ACQUIRES PFIZER CONSUMER HEALTHCARE DIVISION
J&J ACQUIRES PFIZER CONSUMER HEALTHCARE DIVISION
June 30, 2006
Johnson & Johnson (J&J) is acquiring Pfizer's consumer healthcare division for $16.6 billion.
The deal allows J&J to expand beyond its device and diagnostics and drug divisions, and gives the company rights to Pfizer's over-the-counter products.
The company is aiming to balance its programs between its device and drug businesses, at 35 and 40 percent, respectively, with a consumer healthcare business at 25 percent.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct